| Date | Topics | Speaker, Designation | Webinar |
|---|---|---|---|
| 15-Nov-2024 | Writing a Research Grant |
Duncan Gilbert,
MRC Clinical Trials Unit at UCL |
View |
| 04-Oct-2024 | Patient and Public Involvement in Research |
Richard Stephens,
Patient Advocate |
View |
| 02-Aug-2024 | Research in Health Economics | Victoria Fan,
Former senior fellow at Center for Global Development |
View |
| 12-Jul-2024 | Overview of Sample size Calculation for Clinical Trials |
Allan Hackshaw,
Cancer Research UK & UCL Cancer Trials Centre |
View |
| 28-Jun-2024 | Cancer Survivorship, Priorities and Challenges for Research |
Bogda Koczwara,
Flinders Medical Centre and Flinders University |
View |
| 07-Jun-2024 | Prediction models in healthcare: an introduction |
Richard Riley,
Professor of Biostatistics at the University of Birmingham |
View |
| 10-May-2024 | Survey methods and measures in Clinical Research |
Sudha Sivaram,
NCI Center for Global Health |
View |
| 12-Apr-2024 | Overview of Implementing a Research Study |
Ruth Langley,
MRC Clinical Trials Unit at UCL |
View |
| 01-Apr-2023 | Overview of REDCap (Research Electronic Data Capture) |
Indranil Mallick,
Consultant Radiation Oncologist Tata Medical Centre, Kolkata |
View |
| 03-Dec-2022 | Quality of Life Research in Oncology |
Pernilla Lagergren,
Imperial College London and Karolinska Institutet, Sweden |
View |
| 03-Sep-2022 | Oncology research in LMICs |
Ian F Tannock,
Emeritus Professor of Medicine and Medical Biophysics at Princess Margaret Cancer Centre and University of Toronto |
View |
| 06-Feb-2021 | Can we believe what we read? How to evaluate reports of clinical studies |
Ian F Tannock,
Emeritus Professor of Medicine and Medical Biophysics at Princess Margaret Cancer Centre and University of Toronto |
View |
| 23-Jan-2021 | Measuring and valuing health for cancer therapies |
John Cairns,
Health Economics, London School of Hygiene and Tropical Medicine |
View |
| 07-Nov-2020 | Outcome Measures in Clinical Trials | Marc Buyse,
Founder, International Drug Development Institute |
View |
| 10-Oct-2020 | The Impact of Health Technology Assessment (HTA) in Decision Making in Oncology | Francoise Cluzeau,
Imperial College, London and International Decision Support Initiative (iDSI) Richard Sullivan, Director, Institute of Cancer Policy, King's College London |
View |
| 26-Sep-2020 | Principles of Health Technology Assessment in Oncology | Francis Ruiz,
Former senior policy analyst, International Decision Support Initiative (iDSI) John Cairns, Professor of Health Economics, London School of Hygiene and Tropical Medicine |
View |
| 09-Sep-2020 | Time to Event (survival) Analysis |
Allan Hackshaw,
Cancer Research UK & UCL Cancer Trials Centre |
View |
| 09-Nov-2019 | Sample size considerations for comparative clinical Trials | Mark Krailo,
Professor, University of Southern California and Senior Statistician, Children's Oncology Group |
View |
| 05-Oct-2019 | Essentials of Randomized Trials | Marc Buyse,
Founder, International Drug Development Institute |
View |